Medical Marijuana (OTCMKTS:MJNA – Get Free Report) is one of 258 public companies in the “Drug Manufacturers—Specialty & Generic” industry, but how does it compare to its peers? We will compare Medical Marijuana to similar companies based on the strength of its institutional ownership, profitability, valuation, dividends, analyst recommendations, earnings and risk.
Profitability
This table compares Medical Marijuana and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Medical Marijuana | N/A | N/A | N/A |
| Medical Marijuana Competitors | -86.05% | -59.51% | -13.31% |
Valuation and Earnings
This table compares Medical Marijuana and its peers top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Medical Marijuana | N/A | N/A | -0.59 |
| Medical Marijuana Competitors | $3.53 billion | -$46.51 million | 117.90 |
Medical Marijuana’s peers have higher revenue, but lower earnings than Medical Marijuana. Medical Marijuana is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Insider and Institutional Ownership
0.0% of Medical Marijuana shares are owned by institutional investors. Comparatively, 25.1% of shares of all “Drug Manufacturers—Specialty & Generic” companies are owned by institutional investors. 26.2% of shares of all…